Switching treatments
1 paper1 finding
- 1 lab
- Humans1
Associations
1Adverse events
upin humans1
1 study
Adverse events
upin humans1
Switching treatments raise the risk of adverse events in humans (p <0.001).
“Participants who switched treatments consistently reported higher overall and category-specific AE rates (all p <0.001)”
Humansswitching GLP-1/GIP therapies vs continuous single treatment
ADA Scientific Sessions 2026 abstract5 Jun 2026
Latest
1 in 12 monthsADA Scientific Sessions 2026 Abstract
Comparing Adverse Event Rates among GLP-1/GIP Therapy Switchers vs. Continuous Use Groups in a Real-World Telehealth Cohort
Cohort study in peopleInterventions